Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Beam Therapeutics Inc (BEAM)

Beam Therapeutics Inc (BEAM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,392,965
  • Shares Outstanding, K 68,136
  • Annual Sales, $ 20 K
  • Annual Income, $ -194,590 K
  • 60-Month Beta 1.21
  • Price/Sales 218,091.98
  • Price/Cash Flow N/A
  • Price/Book 5.97
Trade BEAM with:

Options Overview Details

View History
  • Implied Volatility 72.34%
  • Historical Volatility 66.58%
  • IV Percentile 17%
  • IV Rank 17.56%
  • IV High 129.39% on 01/15/21
  • IV Low 60.18% on 11/15/21
  • Put/Call Vol Ratio 0.51
  • Today's Volume 124
  • Volume Avg (30-Day) 381
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 2,413
  • Open Int (30-Day) 3,526

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.94
  • Number of Estimates 7
  • High Estimate -0.35
  • Low Estimate -1.15
  • Prior Year -0.72
  • Growth Rate Est. (year over year) -30.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
75.34 +5.06%
on 11/30/21
100.06 -20.90%
on 11/09/21
-9.62 (-10.84%)
since 10/29/21
3-Month
75.34 +5.06%
on 11/30/21
116.91 -32.30%
on 09/07/21
-27.74 (-25.95%)
since 08/30/21
52-Week
45.05 +75.70%
on 11/30/20
138.52 -42.86%
on 07/02/21
+31.49 (+66.07%)
since 11/27/20

Most Recent Stories

More News
Beam Therapeutics to Participate in the Jefferies 2021 Virtual London Healthcare Conference

CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines...

BEAM : 79.15 (+3.03%)
Beam Therapeutics Inc. (BEAM) Reports Q3 Loss, Misses Revenue Estimates

Beam Therapeutics Inc. (BEAM) delivered earnings and revenue surprises of 46.15% and -95.19%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?...

BEAM : 79.15 (+3.03%)
Beam Therapeutics Appoints Healthcare Industry Leader John Maraganore, Ph.D., to its Board of Directors

CAMBRIDGE, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines...

BEAM : 79.15 (+3.03%)
Beam Therapeutics Provides Business and Pipeline Updates and Reports Third Quarter 2021 Financial Results

BEAM-101 IND Cleared by FDA for Evaluation as a Treatment for Sickle Cell Disease BEAM-102 IND-Enabling Studies Also Underway CAMBRIDGE, Mass., Nov. 08,...

BEAM : 79.15 (+3.03%)
Beam Therapeutics Announces Upcoming Preclinical Data Presentations at the American Society of Hematology Annual Meeting

Preclinical Data Demonstrates that BEAM-102 Makassar Base Editing Converts Sickle Hemoglobin to Functional Hemoglobin for Potential Treatment of Sickle...

BEAM : 79.15 (+3.03%)
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

Smart Beta ETF report for XBI

XBI : 116.27 (+1.06%)
IBB : 154.22 (-1.18%)
BEAM : 79.15 (+3.03%)
AVXL : 19.40 (-5.09%)
FBT : 156.71 (-1.37%)
NTLA : 115.01 (+2.94%)
Analysts Estimate Beam Therapeutics Inc. (BEAM) to Report a Decline in Earnings: What to Look Out for

Beam Therapeutics Inc. (BEAM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BEAM : 79.15 (+3.03%)
Should You Invest in the SPDR S&P Biotech ETF (XBI)?

Sector ETF report for XBI

XBI : 116.27 (+1.06%)
IBB : 154.22 (-1.18%)
BEAM : 79.15 (+3.03%)
AVXL : 19.40 (-5.09%)
FBT : 156.71 (-1.37%)
NTLA : 115.01 (+2.94%)
Beam Therapeutics to Participate in the Jefferies Gene Therapy/Editing Summit

CAMBRIDGE, Mass., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines...

BEAM : 79.15 (+3.03%)
Sana Biotechnology Obtains a Non-Exclusive License to CRISPR Cas12b Gene Editing Technology from Beam Therapeutics to Enable Engineered Cell Programs

Agreement combines Beam’s gene editing technology with Sana’s ex vivo platform SEATTLE, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc....

SANA : 19.01 (+6.98%)
BEAM : 79.15 (+3.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.

See More

Key Turning Points

3rd Resistance Point 86.45
2nd Resistance Point 83.46
1st Resistance Point 81.31
Last Price 79.15
1st Support Level 76.17
2nd Support Level 73.18
3rd Support Level 71.03

See More

52-Week High 138.52
Fibonacci 61.8% 102.81
Fibonacci 50% 91.78
Fibonacci 38.2% 80.75
Last Price 79.15
52-Week Low 45.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar